FORA Capital’s CureVac CVAC Stock Holding History

FORA Capital’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,469	Closed	-$281K	–	832
2020 Q4	$281K	Buy	+3,469	New	+$266K	0.04%	428

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FORA Capital's CVAC Position: Q1 2021 in Review

FORA Capital sold out of CureVac (CVAC) in Q1 2021, closing a stake of 3,469 shares — an estimated $281K sold.

FORA Capital first reported a position in CVAC in Q4 2020 and held it in 1 quarter. The position peaked at $281K in Q4 2020. 84 funds tracked by Wall St. Rank hold CVAC as of Q1 2021.

FORA Capital reported no remaining CureVac position as of Q1 2021 after selling out during the quarter.
FORA Capital sold 3,469 CureVac shares in Q1 2021, an estimated $281K.
FORA Capital first reported a position in CureVac in Q4 2020 and held it in 1 quarter.
FORA Capital's CureVac position peaked at $281K in Q4 2020.
84 funds tracked by Wall St. Rank held CureVac as of Q1 2021.

Based on FORA Capital's 13F filing for Q1 2021, filed 17 May 2021.